1. Impact of genetic subtypes of Prader–Willi syndrome with growth hormone therapy on intelligence and body mass index
- Author
-
Suzanne B. Cassidy, Merlin G. Butler, Nidhi Patel, Travis Thompson, June-Anne Gold, Virginia Kimonis, Manaswitha Khare, Abhilasha Surampalli, and Naomi A. Matthews
- Subjects
Adult ,Male ,congenital, hereditary, and neonatal diseases and abnormalities ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Intelligence ,Stanford-Binet Test ,Article ,Body Mass Index ,law.invention ,Young Adult ,law ,Genetics ,Humans ,Medicine ,Child ,Genetics (clinical) ,Sequence Deletion ,Intelligence Tests ,Chromosomes, Human, Pair 15 ,Intelligence quotient ,business.industry ,Wechsler Scales ,Stanford–Binet Intelligence Scales ,nutritional and metabolic diseases ,Wechsler Adult Intelligence Scale ,medicine.disease ,Obesity ,nervous system diseases ,Growth hormone treatment ,Phenotype ,Child, Preschool ,Growth Hormone ,Cohort ,Failure to thrive ,Female ,medicine.symptom ,business ,Prader-Willi Syndrome ,Body mass index - Abstract
Prader–Willi syndrome (PWS) is a genomic imprinting disorder characterized by infantile hypotonia with a poor suck and failure to thrive, hypogenitalism/hypogonadism, behavior and cognitive problems, hormone deficiencies, hyperphagia, and obesity. The Stanford Binet and Wechsler (WAIS-R; WISC-III) intelligence (IQ) tests were administered on 103 individuals with PWS from two separate cohorts [University of California, Irvine (UCI) (N = 56) and Vanderbilt University (N = 47)] and clinical information obtained including growth hormone (GH) treatment, PWS molecular classes, weight and height. Significantly higher IQ scores (p < .02) were found representing the vocabulary section of the Stanford Binet test in the growth hormone (GH) treated group when compared with non-GH treatment in the pediatric-based UCI PWS cohort with a trend for stabilization of vocabulary IQ scores with age in the GH treated maternal disomy (UPD) 15 subject group. Significant differences (p = .05) were also found in the adult-based Vanderbilt PWS cohort with 15q11-q13 deletion subjects having lower Verbal IQ scores compared with UPD 15. No difference in body mass index was identified based on the PWS molecular class or genetic subtype. Medical care and response to treatment with growth hormone may influence intelligence impacted by PWS genetic subtypes and possibly age, but more studies are needed.
- Published
- 2019
- Full Text
- View/download PDF